The Soterix Medical mini-CT captures the features of the clinical trial standard 1×1-CT in a deployable platform. Supervised neuromodulation guarantees over site at the start and completion of every session, ensured by unique mini-CT features. Two models, the 1×1 tDCS mini-CT and the 1×1 tES mini-CT, provide unmatched controlled and reliability in conducting tDCS or tES trials in deployed environments without compromising dose precision and safety.


Supervised Neuromodulation

This schematic illustrates the principle of supervised neuromodulation. While not intended to capture the details of device and headgear design (which are customized for each use), or the trial specific technology of telemedicine (including use of text or video conferencing), the principle or supervision at the start and completion of each trial is highlighted. Without compliance and control, remote use of neuromodulation will not meet medical standards.


1×1 tES mini-CT

  • Remote supervised delivery of tDCS, tACS, tRNS, or tPCS
  • tES-LTE enabled
  • Simple interface
  • Customized accessories
  • Very compact design
  • Secure administrator mode to program sessions
  • Storage: 1800 Session
  • Intelligent power management to maximize battery life
  • Power: one internal rechargable battery

1×1 tDCS mini-CT

  • Cost effective device for remote supervised tDCS
  • tDCS-LTE enabled
  • Simple interface
  • Customized accessories
  • Compact design
  • Secure administrator mode to program sessions
  • Storage: 250 sessions
  • Intelligent power management to maximize battery life
  • Power: one 9v Battery


Learn more about Soterix Medical mini-CT Devices for Remote Neuromodulation, please click https://soterixmedical.com/research/remote/mini-CT or reach us at contact@amperemedical.com.hk.